Literature DB >> 22649006

Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.

Juho Joutsa1, Kirsti Martikainen, Solja Niemelä, Jarkko Johansson, Sarita Forsback, Juha O Rinne, Valtteri Kaasinen.   

Abstract

BACKGROUND: Impulse control disorders (ICDs) occur frequently in PD patients.
METHODS: To investigate the possible involvement of the mesostriatal and mesolimbic monoaminergic function in ICDs associated with PD, we examined patients with (n = 10) and without (n = 10) ICDs using the brain [(18) F]fluorodopa PET.
RESULTS: Patients with ICDs (e.g., pathological gambling, hypersexuality, and compulsive eating) showed up to 35% higher [(18) F]fluorodopa uptake in the medial orbitofrontal cortex, compared to control patients, but no differences in the striatum. The results remained significant also after excluding subjects with comorbid psychiatric disorders.
CONCLUSIONS: Increased monoaminergic activity in the medial orbitofrontal cortex might be associated with increased sensitivity for ICDs under dopamine-replacement therapy in PD.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649006     DOI: 10.1002/mds.24941

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

2.  Molecular imaging of impulse control disorders in Parkinson's disease.

Authors:  Joonas Majuri; Juho Joutsa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-31       Impact factor: 9.236

3.  Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.

Authors:  Daniel O Claassen; Adam J Stark; Charis A Spears; Kalen J Petersen; Nelleke C van Wouwe; Robert M Kessler; David H Zald; Manus J Donahue
Journal:  Mov Disord       Date:  2017-06-19       Impact factor: 10.338

4.  Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.

Authors:  I Navalpotro-Gomez; R Dacosta-Aguayo; F Molinet-Dronda; A Martin-Bastida; A Botas-Peñin; H Jimenez-Urbieta; M Delgado-Alvarado; B Gago; A Quiroga-Varela; Maria C Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

Review 5.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

6.  Parallel appearance of compulsive behaviors and artistic creativity in Parkinson's disease.

Authors:  Juho Joutsa; Kirsti Martikainen; Valtteri Kaasinen
Journal:  Case Rep Neurol       Date:  2012-05-09

7.  Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease.

Authors:  Lucio Marinelli; Arnoldo Piccardo; Laura Mori; Silvia Morbelli; Nicola Girtler; Antonio Castaldi; Agnese Picco; Carlo Trompetto; Maria Felice Ghilardi; Giovanni Abbruzzese; Flavio Nobili
Journal:  Parkinsons Dis       Date:  2015-06-11

Review 8.  Hypersexuality in Parkinson's Disease: Systematic Review and Report of 7 New Cases.

Authors:  David Codling; Philip Shaw; Anthony S David
Journal:  Mov Disord Clin Pract       Date:  2015-04-30

Review 9.  Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders.

Authors:  George B Stefano; Radek Ptáček; Hana Kuželová; Kirk J Mantione; Jiří Raboch; Hana Papezova; Richard M Kream
Journal:  Med Sci Monit       Date:  2013-05-10

10.  Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's disease.

Authors:  Andrew D Lawrence; David J Brooks; Alan L Whone
Journal:  Front Psychol       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.